HEALING FLARE IN SKELETAL METASTASES FROM BREAST-CANCER

被引:48
作者
JANICEK, MJ [1 ]
HAYES, DF [1 ]
KAPLAN, WD [1 ]
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DANA FARBER CANC INST,CTR BREAST EVAULAT,BOSTON,MA 02115
关键词
BONE NEOPLASMS; METASTASES; BREAST NEOPLASMS;
D O I
10.1148/radiology.192.1.8208938
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To identify the frequency, characteristics, and prognostic significance of scintigraphically detected healing flare in patients with breast cancer metastatic to bone. MATERIALS AND METHODS: Findings on bone scans and concomitant radiographs of 1,188 patients were reviewed. Bone metastases occurred in 426 patients. Outcomes of 101 patients (aged 21-71 years) with skeletal metastases were correlated with typical scintigraphic and radiographic features. RESULTS: Healing flare with increased radiotracer uptake and radiographically demonstrated sclerotic changes in osteolytic or mixed skeletal metastases were prospectively identified in 12% of patients with skeletal metastases. Healing flare was detected 3.2 months a 1.4 after initiation of hormonal treatment or chemotherapy. Skeletal metastatic activity stabilized on bone scans within 6.2 months +/- 3.0. Patients with healing flare did not survive longer than patients without healing flare but with stable metastases after treatment (3.3 years +/- 2.0 vs 3.9 years +/- 1.6). CONCLUSION: Scintigraphically detected healing flare represents a favorable response to therapy not associated with increased survival.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 19 条
  • [1] COMPARISON OF COMPUTED-TOMOGRAPHY AND CONVENTIONAL RADIOLOGY IN THE ASSESSMENT OF TREATMENT RESPONSE OF LYTIC BONY METASTASES IN PATIENTS WITH CARCINOMA OF THE BREAST
    BELLAMY, EA
    NICHOLAS, D
    WARD, M
    COOMBES, RC
    POWLES, TJ
    HUSBAND, JE
    [J]. CLINICAL RADIOLOGY, 1987, 38 (04) : 351 - 355
  • [2] BITRAN JD, 1980, CANCER, V45, P1562, DOI 10.1002/1097-0142(19800401)45:7<1562::AID-CNCR2820450709>3.0.CO
  • [3] 2-G
  • [4] BLOMQVIST C, 1987, CANCER-AM CANCER SOC, V60, P2907, DOI 10.1002/1097-0142(19871215)60:12<2907::AID-CNCR2820601211>3.0.CO
  • [5] 2-B
  • [6] COLEMAN RE, 1988, J NUCL MED, V29, P1354
  • [7] HAYES DF, 1991, BREAST DISEASES, P505
  • [8] HORTOBAGYI G N, 1991, Seminars in Oncology, V18, P11
  • [9] HORTOBAGYI GN, 1984, CANCER, V53, P577, DOI 10.1002/1097-0142(19840201)53:3<577::AID-CNCR2820530335>3.0.CO
  • [10] 2-U